Gilead Sciences (France)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (France), France, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
55%
Total
Publications
245
Total Open
Publications
135
Total
Citations
5.6K
Open Access
Percentage
55%
Total
Publications
245
Total Open
Publications
135
Total
Citations
5.6K
Breakdown
Publisher Open
31%
Both
16%
Other Platform Open
8%
Closed
45%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
34
Hybrid 18%
21
No Guarantees 53%
61
Other Platform Open
Domain 64%
38
Institution 42%
25
Preprint 19%
11
Other Internet 10%
6
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 39 |
doaj.org OAI-PMH Repository | Institution | 9 |
Research Square | Preprint | 6 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 6 |
Unknown Repository | Other Internet | 5 |
cas.cz OAI-PMH Repository | Institution | 3 |
bioRxiv | Preprint | 3 |
Washington University in St. Louis | Institution | 2 |
University of Toronto | Institution | 2 |
University of Manchester | Institution | 2 |